Clinicopathological correlative analysis of epidermal growth factor receptor gene in colorectal carcinoma

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 3, 2008, Pages 206-210

  Lü, Yang ^a   Chen, Wei ^a   Zhao, Po ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Colorectal neoplasms; Gene, EGFR; Immunohistochemistry; Somatic mutations

Indexed keywords

EID: 84655169453     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 2002, 11 (5):250-260.
2. Mayer A, Takimoto M, Fritz E, et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer[J]. Cancer, 1993, 71: 2454- 2460.
3. John H S, Laura E C, Samson L, et al. Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors [J]. PNAS, 2000, 97(13):7503-7508.
4. Khazaie K, Schirrmacher V, Lichtner R B. EGF receptor in neoplasia and metastasis [J]. Cancer Metastasis Rev, 1993, 12: 255-274.
5. Hildebrandt M, Mapara M Y, Korner I J, et al. Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency [J]. Exp Hematol, 1997, 25: 57-65.
6. Baselga J, Mendelsohn J. The epidermal growth factor receptor as a target for therapy in breast carcinoma [J]. Breast Cancer Res Treat, 1994, 29: 127-138.
7. Witters L, Kumar R, Mandal M, et al. Antisense oligonucleotides to the epidermal growth factor receptor [J]. Breast Cancer Res Treat, 1999, 53: 41-50.
8. Naruse I, Ohmori T, Ao Y, et al. Antitumor activity of the selective epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR expressing multidrug resistant cell line in vitro and in vivo [J]. Int J Cancer, 2002, 98: 310-315.
9. Rusch V, Baselga J, Cordon-Cardo C, et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung[J]. Cancer Res, 1993, 53: 2379-2385.
10. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J]. N Engl J Med, 2004, 351: 337-345.
11. 2004, 13(4): 253-256.
12. 2003, 15(5):314-316.
13. Hisashi N, Koshi M, Mitsuhiko O, et al. Somatic Mutations of Epidermal Growth Factor Receptor in Colorectal Carcinoma[J]. Clinical Cancer Research, 2005, 11: 1368-1371.
14. Schlessinger J, Ullrich A. Growth-factor signaling by receptor tyrosine kinase[J]. Neuron, 1992, 9: 383-391.
15. Rajkumar T. Growth factors and growth factor receptors in cancer (Review)[J]. Curr Sci, 2001, 81(5): 535-541.
16. Yamazaki H, Kijima H, Ohnishi Y, et al. Inhibition of tumor growth by ribozyme mediated suppression of aberrant epidermal growth factor receptor gene expression [J]. J Natl Cancer Inst, 1998, 90:581-587.
17. DiCarlo A, Mariano A, D'Alessandro V, et al. Evaluation of epidermal growth factor receptor, carcinoembryonic antigen ana Lewis carbohydrate antigens in human colorectal and liver neoplasias[J]. Oncol Rep, 2001, 8(2): 387-392.